Clinical Trial

Phase II Trial of Consolidative Thoracic Radiotherapy for ES-SCLC After Standard Care of Chemo-immunotherapy

Recruiting
View on ClinicalTrials.gov →
Summary
This is an open-label, single arm Phase II study designed to evaluate the efficacy and safety of thoracic radiotherapy for extensive-stage small-cell lung cancer treated with PD-1/PD-L1 plus etoposide platinum followed by PD-1/PD-L1 maintenance therapy
Protocol Amendment History 2 changes
notable Primary completion pushed: 2025-09-30 -> 2027-09-30 2026-08-13
minor Completion pushed: 2026-09-30 -> 2027-09-30 2026-08-13
Trial Details
NCT Number NCT05552846
Lead Sponsor Ruijin Hospital
Conditions Small-cell Lung Cancer
Enrollment 104 participants
Start Date 2021-01-30
Primary Completion 2027-09-30 (estimated)
Study Completion 2027-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-12